Quantum量子訊息有限公司
← 最新全球產業報告

Nicotinamide Market

研究執行與發布:TechSci Research · 發布日期 2026-05-01 · 180 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 TechSci Research產業別 Chemicals & Materials出版日期 2026-05-01頁數 180報告編號 TSR-28767

授權報價

Single User License$4,500 USD
Multiple User License$5,500 USD
Custom Research License$8,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals), By Region & Competition, 2021-2031F

報告摘要

Market Overview The global nicotinamide market is projected to expand significantly, rising from USD 717.21 million in 2025 to USD 1063.13 million by 2031, demonstrating a compound annual growth rate of 6.78%. Nicotinamide, a crucial water-soluble form of Vitamin B3, is widely incorporated into pharmaceutical products, cosmetic formulations, and animal nutrition. This market growth is primarily fueled by the increasing incidence of dermatological conditions that require effective skin barrier solutions, alongside the substantial growth of the global livestock industry's demand for high-performance feed additives for disease prevention. Additionally, a growing consumer focus on preventative healthcare significantly increases the industrial consumption of vitamin-based dietary supplements. However, the market faces considerable hurdles, particularly concerning supply chain instability and the concentrated nature of its manufacturing base. A strong dependence on specific regions for synthesizing raw materials makes the market susceptible to trade shifts and logistical delays, hindering consistent sourcing. For instance, the European Feed Manufacturers' Federation reported in 2025 that the European Union imported over 75% of its Vitamin B3, highlighting the substantial risks linked to centralized global production and potential disruptions for related industries. Market Driver The global nicotinamide market is undergoing a significant transformation driven by the escalating demand for cosmeceuticals and anti-aging skincare products, owing to the compound's recognized efficacy in improving skin barrier function and diminishing hyperpigmentation. Cosmetic companies are actively integrating high-purity Vitamin B3 into various serums and creams to satisfy a knowledgeable consumer base seeking versatile active ingredients. This trend is supported by substantial consumer engagement; a November 2025 Foundation report, 'New data reveals top skincare ingredients of 2024', identified Niacinamide as the fourth most searched skincare ingredient, affirming its crucial position in contemporary beauty routines alongside established compounds like retinol. This enduring popularity is prompting chemical suppliers to increase production of cosmetic-grade nicotinamide to fulfill the personal care sector's stringent purity standards. Concurrently, market growth is fueled by the expanding animal feed sector, propelled by global livestock production, where nicotinamide is a vital additive for enhancing metabolic health and preventing diseases in poultry and swine. With increasing global meat consumption, the industrial demand for feed-grade vitamins intensifies, crucial for ensuring peak herd performance and food security. The '2025 Agri-Food Outlook' by Alltech (November 2025) noted a 1.2% rise in global feed production in 2024, reaching 1.396 billion metric tons, which directly translates to greater Vitamin B3 procurement. Further underscoring this sector's strength, dsm-firmenich reported in February 2025 that their Animal Nutrition & Health unit achieved 5% organic sales growth in 2024, indicating strong commercial vibrancy within the livestock nutrition landscape. Market Challenge The global nicotinamide market encounters a major obstacle to its expansion stemming from the pronounced geographic centralization of its manufacturing operations. This profound dependence on a restricted number of regional production centers establishes a vulnerable supply chain structure, making it susceptible to widespread availability problems triggered by isolated local incidents like regulatory changes or logistical disruptions. As a result, downstream industries often experience significant price fluctuations and irregular raw material supplies, which impedes their capacity for long-term growth planning and destabilizes the consistent market evolution needed. The profound nature of this structural weakness is clearly demonstrated by recent trade statistics, which highlight the market's reliance on particular export sources. Data from the China Chamber of Commerce for Import & Export of Medicines & Health Products indicated that in 2024, China's total vitamin exports reached approximately USD 3.45 billion, with the U.S. market alone importing USD 840 million of this amount. This figure reveals a crucial bottleneck where global supply stability is intrinsically linked to the production capabilities of a single nation, thereby generating a risk landscape that discourages investment and introduces inefficiencies within the global distribution framework. Market Trends Manufacturers are progressively moving away from conventional chemical synthesis towards environmentally friendly biomanufacturing techniques, specifically employing chemo-enzymatic and microbial fermentation processes. This transition aims to reduce environmental impact and ensure adherence to regulatory standards. This strategic shift differs significantly from typical supply chain modifications, as its core objective is to minimize the carbon footprint of production to attract stakeholders focused on sustainability. Leading industry participants are formalizing these pledges with stringent validation frameworks, guaranteeing that their manufacturing innovations align with global climate benchmarks. For example, Lonza's 'Sustainability Report 2024' (April 2025) confirmed that its near-term greenhouse gas reduction targets were validated by the Science Based Targets Initiative in 2024, with a commitment to cut absolute Scope 1 and 2 emissions by 42% by 2030, thereby establishing a new standard for eco-efficient nicotinamide manufacturing. Concurrently, the market is experiencing a notable expansion into the male grooming segment, spurred by a demographic change where men are increasingly seeking functional skincare components such as Nicotinamide due to its non-greasy, barrier-reinforcing attributes. This trend is distinct from the wider cosmeceutical demand for general anti-aging formulations, as it specifically targets male consumers who leverage digital platforms to research ingredient effectiveness and product choices. This heightened engagement is reflected in social media search patterns indicating specific ingredient interest. A July 2025 'Men's Trends Report' by Cosmetics Business revealed a 35% increase in searches for niacinamide serum among male Pinterest users, underscoring the ingredient's growing prominence as a key component in men's personal care routines. Key Market Players * Nebula Health Care * Suchem Laboratory * Western Drugs Limited * Roopa industries limited * S.V. Labs Pvt. Ltd. * Veer Chemie & Aromatics pvt ltd. * Optimus Drugs Pvt. Ltd * NIGAM FINECHEM PVT. LTD * Ishita Drugs & Industries Ltd * Anhui Redpont Biotechnology Co., Ltd Report Scope In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # Nicotinamide Market, By Sales Channel * Direct * Indirect # Nicotinamide Market, By End Use * Pharmaceuticals * Cosmetics & Personal Care * Food & Beverages * Animal Feed * Chemicals # Nicotinamide Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market. Available Customizations: Global Nicotinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global Nicotinamide Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Sales Channel (Direct, Indirect) 5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals) 5.2.3. By Region 5.2.4. By Company (2025) 5.3. Market Map 6. North America Nicotinamide Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Sales Channel 6.2.2. By End Use 6.2.3. By Country 6.3. North America: Country Analysis 6.3.1. United States Nicotinamide Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Sales Channel 6.3.1.2.2. By End Use 6.3.2. Canada Nicotinamide Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Sales Channel 6.3.2.2.2. By End Use 6.3.3. Mexico Nicotinamide Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Sales Channel 6.3.3.2.2. By End Use 7. Europe Nicotinamide Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Sales Channel 7.2.2. By End Use 7.2.3. By Country 7.3. Europe: Country Analysis 7.3.1. Germany Nicotinamide Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Sales Channel 7.3.1.2.2. By End Use 7.3.2. France Nicotinamide Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Sales Channel 7.3.2.2.2. By End Use 7.3.3. United Kingdom Nicotinamide Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Sales Channel 7.3.3.2.2. By End Use 7.3.4. Italy Nicotinamide Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Sales Channel 7.3.4.2.2. By End Use 7.3.5. Spain Nicotinamide Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Sales Channel 7.3.5.2.2. By End Use 8. Asia Pacific Nicotinamide Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Sales Channel 8.2.2. By End Use 8.2.3. By Country 8.3. Asia Pacific: Country Analysis 8.3.1. China Nicotinamide Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Sales Channel 8.3.1.2.2. By End Use 8.3.2. India Nicotinamide Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Sales Channel 8.3.2.2.2. By End Use 8.3.3. Japan Nicotinamide Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Sales Channel 8.3.3.2.2. By End Use 8.3.4. South Korea Nicotinamide Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Sales Channel 8.3.4.2.2. By End Use 8.3.5. Australia Nicotinamide Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Sales Channel 8.3.5.2.2. By End Use 9. Middle East & Africa Nicotinamide Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Sales Channel 9.2.2. By End Use 9.2.3. By Country 9.3. Middle East & Africa: Country Analysis 9.3.1. Saudi Arabia Nicotinamide Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Sales Channel 9.3.1.2.2. By End Use 9.3.2. UAE Nicotinamide Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Sales Channel 9.3.2.2.2. By End Use 9.3.3. South Africa Nicotinamide Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Sales Channel 9.3.3.2.2. By End Use 10. South America Nicotinamide Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Sales Channel 10.2.2. By End Use 10.2.3. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Nicotinamide Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Sales Channel 10.3.1.2.2. By End Use 10.3.2. Colombia Nicotinamide Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Sales Channel 10.3.2.2.2. By End Use 10.3.3. Argentina Nicotinamide Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Sales Channel 10.3.3.2.2. By End Use 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Global Nicotinamide Market: SWOT Analysis 14. Porter's Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. Nebula Health Care 15.1.1. Business Overview 15.1.2. Products & Services 15.1.3. Recent Developments 15.1.4. Key Personnel 15.1.5. SWOT Analysis 15.2. Suchem Laboratory 15.3. Western Drugs Limited 15.4. Roopa industries limited 15.5. S.V. Labs Pvt. Ltd. 15.6. Veer Chemie & Aromatics pvt ltd. 15.7. Optimus Drugs Pvt. Ltd 15.8. NIGAM FINECHEM PVT. LTD 15.9. Ishita Drugs & Industries Ltd 15.10. Anhui Redpont Biotechnology Co., Ltd 16. Strategic Recommendations 17. About Us & Disclaimer

提及公司

1 Nebula Health Care2 Suchem Laboratory3 Western Drugs Limited4 Roopa industries limited5 S.V. Labs Pvt. Ltd.6 Veer Chemie & Aromatics pvt ltd.7 Optimus Drugs Pvt. Ltd8 NIGAM FINECHEM PVT. LTD9 Ishita Drugs & Industries Ltd10 Anhui Redpont Biotechnology Co., Ltd

同分類最新報告(化學與材料)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 TechSci Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們